Archit Organosys Approves Capital Hike and Share Swap Acquisition of Archit Life Science
Archit Organosys Ltd 路 Outcome 路 03 Sept 2026, 11:56 pm
Archit Organosys Approves Capital Hike and Share Swap Acquisition of Archit Life Science On 3rd Sep'26, Archit Organosys approved increasing its authorised share capital from Rs 25 crore to Rs 60 crore to facilitate a major acquisition. The board cleared a preferential issue of 3,72,48,344 equity shares via a share swap at Rs 65 per share. This issuance funds the acquisition of a 92.20% stake (1,86,24,172 shares) in Archit Life Science Limited, valuing the target's shares at Rs 130 each. The strategic transaction involves promoter and non-promoter allottees and remains subject to final shareholder and regulatory approvals.
Original exchange filing (PDF)
More announcements from Archit Organosys Ltd
- Announcement of Unaudited Financial result for quarter and half year ended on September 30, 2026. 路 04 Nov 2026
- Outcome Of Board Meeting 路 04 Nov 2026
- Archit Organosys Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the unaudited financial result .... 路 04 Nov 2026
- Voting result for 33rd Annual General Meeting 路 02 Oct 2026
- Outcome of 33rd Annual general Meeting 路 30 Sept 2026
- Corrigendum to the Annual Report for FY 2025-26 路 25 Sept 2026
- Corrigendum to the Notice of 33rd Annual General Meeting to be held on 30.09.2026 路 25 Sept 2026
- Outcome of the board meeting held on 23.09.2026 for withdrawal of agenda items from notice convening ensuing annual general meeting 路 24 Sept 2026
